A panel consisting of CCL21, FLT3L, and IL-13 appeared to demonstrate significant power to distinguish between CTE, AD, and PSP, while CBD and AGD were a more ambiguous. This evidence concerns the gene IL13 and supranuclear palsy, progressive, 1.